Thessalus is a leading, “content strong” investment firm specializing in US and international life science industries. We have narrow and deep focus on pharmaceuticals, biotechnology, diagnostic tools, and medical devices.
We take a global, research-heavy approach, to allocate investment in areas of greatest medium and long term potential. The company creates and executes strategic transactions for growth and to maximize shareholder value.
Thessalus has a research-heavy, sector-focused approach to investing in the healthcare industry. We invest in life science companies where our research points to unrealized, unprecedented opportunity for a company’s rapid growth, enhanced operational capability, and competitiveness. We invest in healthcare companies and sectors where the firm has specialized knowledge and expertise.
The team has general management and a specialized healthcare skill sets which support the strategic growth and successful track record of the fund. Operations are guided by machine-driven algorithms which are data-driven and statistically sound, created in collaboration with mathematical and engineering faculty at leading academic institutions.
The team has general management and a specialized healthcare skill sets which support the strategic growth and successful track record of the fund.